According to a multinational clinical trial involving nearly 20,000 young women, the human papilloma virus vaccine, Cervarix, not only has the potential to prevent cervical cancer, but was effective against other common cancer-causing human papillomaviruses, aside from just the two HPV types, 16 and 18, which are responsible for about 70 percent of all cases.
from The Medical News http://ift.tt/1BfYY7Z
from The Medical News http://ift.tt/1BfYY7Z
No comments:
Post a Comment